American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 743-753 , November 2007

CKD as a Risk Factor for Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

  • Shiu-Dong Chung, MD

      Affiliations

    • Department of Surgery, Division of Urology, Far Eastern Memorial Hospital, Ban-Ciao
    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Kuo-How Huang, MD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Ming-Kuen Lai, MD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Chao-Yuan Huang, MD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Chung-Hsin Chen, MD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Yeong-Shiau Pu, MD, PhD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Hong-Jeng Yu, MD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • ,
  • Shih-Chieh Chueh, MD, PhD

      Affiliations

    • Department of Urology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
    • Corresponding Author InformationAddress correspondence to Shih-Chieh Chueh, MD, PhD, Department of Urology, National Taiwan University Hospital, #7 Chung-Shan South Rd, Taipei, Taiwan 100.

Received 24 March 2007 ,Accepted 7 August 2007.

References 

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin. 1998;48:6–29
  2. Yang MH, Chen KK, Yen CC, et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology. 2002;59:681–687
  3. Hsieh YF, Ling GC, Lu YB, Yeh MT, Chiang CP. Incidence of tumor of the renal pelvis in Taiwan. J Formos Med Assoc. 1979;78:749–753
  4. Cummings KB. Nephroureterectomy: Rationale in the management of primary transitional cell carcinoma of the upper urinary tract. Urol Clin North Am. 1980;7:569–578
  5. Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol. 2005;174:2120–2123
  6. Akdogan B, Dogan HS, Eskicorapsi SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006;176:48–52
  7. Langner C, Hutterer G, Chromecki T, Leibl S, Rehak P, Ziguener R. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J Urol. 2006;176:910–913
  8. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology. 1998;52:594–601
  9. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004;171:621–625
  10. Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005;65:279–283
  11. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet. 1999;354:93–99
  12. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML. Urologic cancers in uremic patients. Am J Kidney Dis. 1995;25:694–700
  13. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  14. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  15. American Joint Committee on Cancer. Renal pelvis and ureter. In: AJCC Cancer Staging Manual. ed 6. New York, NY: Springer; 2002;p. 329–334
  16. Mostofi FK, Sorbin LH, Torloni H. Histological Typing of Urinary Bladder Tumors (International Histological Classification of Tumors). No. 10 Geneva, Switzerland: World Health Organization; 1973;
  17. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14:197–207
  18. Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: Potential factors involved. Am J Nephrol. 1998;18:89–95
  19. Stopper H, Meysen T, Bockenforde A, Bahner U, Heidland A, Vamvakas S. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis. 1999;34:433–437
  20. Kohler H, Girndt M, Dumann H, Klingel R. [The immune defect in kidney failure. II. The mechanisms of the “uremic” immune defect]. Dtsch Med Wochenschr. 1993;118:790–795
  21. Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pan ST. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol. 2006;176:477–481
  22. Kang CH, Yu TJ, Hsieh HH, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer. 2003;98:1620–1626
  23. Ou JH, Pan CC, Lin JS, et al. Transitional cell carcinoma in dialysis patients. Eur Urol. 2000;37:90–94
  24. Takahashi T, Habuchi T, Kakehi Y, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 1998;58:5835–5841
  25. Vriesema JL, Aben KK, Witjes JA, Kiemeney LA, Schalken JA. Superficial and metachronous invasive bladder carcinomas are clonally related. Int J Cancer. 2001;93:699–702
  26. Hafner C, Knuechel R, Zarnado L, et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene. 2001;20:4910–4915
  27. Ziguener RE, Hutterer G, Chromacki T, Rehak P, Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006;98:1181–1186
  28. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006;27:112–116
  29. Hartge P, Silverman D, Hoover R, et al. Changing cigarette habits and bladder cancer risk: A case-control study. J Natl Cancer Inst. 1987;78:1119–1125
  30. Raman JD, Ng CK, Boorjian SA, Vaughan ED, Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology. BJU Int. 2005;96:1031–1035

 Originally published online as doi:10.1053/j.ajkd.2007.08.007 on October 8, 2007.

PII: S0272-6386(07)01143-2

doi: 10.1053/j.ajkd.2007.08.007

American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 743-753 , November 2007

Article Tools

* Image Usage & Resolution